India's Pharmaceutical Exports

Country Profile

Timor-Leste

Timor-Leste is a developing market for Indian pharmaceuticals — $2.29M in FY 2025–26, with 2.1× growth over the past decade. Medicines accounts for 57% of shipments, with vaccines contributing $938K. The compound annual growth rate since FY2015 stands at 7.1%.

🇹🇱 $2.29M · 2.1× growth since FY2015 · 7.1% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$2.29M
Exports FY2025–26 DGCIS
2.1×
Growth FY2015→2026
7.1%
CAGR FY2015→2026
57%
Medicines Share
3
Product Categories Supplied
Timor-Leste is a developing market for Indian pharmaceuticals — $2.29M in FY 2025–26, with 2.1× growth over the past decade. Medicines accounts for 57% of shipments, with vaccines contributing $938K. The compound annual growth rate since FY2015 stands at 7.1%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $1.30M (56.9%) Vaccines $938K (40.9%) Surgical & Hospital Supplies $50K (2.2%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Timor-Leste in the RBI overseas direct investment dataset (2011–2026).